For example, an RCT of pravastatin, which does not readily cross the BBB and does not have affinity for P-glycoprotein, also found a small reduction in positive symptoms at 6 weeks in patients with schizophrenia,9 perhaps suggesting that alternative mechanisms may play a role. Here, ABCB1 is linked to schizophrenia.